Related Experiment Videos
Persistent induction of c-fos and c-jun expression by asbestos
N H Heintz1, Y M Janssen, B T Mossman
1Department of Pathology, University of Vermont College of Medicine, Burlington 05405.
Summary
Asbestos exposure persistently increases c-fos and c-jun protooncogenes in mesothelial cells, unlike other agents. This sustained activation of early response genes may drive asbestos-induced carcinogenesis and cell proliferation.
Area of Science:
- Molecular Biology
- Toxicology
- Oncology
Background:
- Asbestos exposure is a known cause of mesothelioma and lung cancer.
- The molecular mechanisms underlying asbestos-induced carcinogenesis are not fully understood.
- Protooncogenes like c-fos and c-jun play critical roles in cell proliferation and differentiation.
Purpose of the Study:
- To investigate the role of c-fos and c-jun protooncogene expression in asbestos-induced carcinogenesis.
- To compare the effects of different asbestos types (crocidolite and chrysotile) on gene expression.
- To explore the activation of transcription factors involved in asbestos-related cellular responses.
Main Methods:
- Exposure of rat pleural mesothelial cells and hamster tracheal epithelial cells to crocidolite and chrysotile asbestos.
- Quantitative analysis of c-fos and c-jun mRNA and protein levels.
- Assessment of DNA-binding activity of AP-1 transcription factors.
Main Results:
- Asbestos exposure caused a persistent, dose-dependent increase in c-fos and c-jun mRNA in mesothelial cells, unlike transient induction by phorbol esters.
- Crocidolite asbestos, more pathogenic for mesothelioma, induced a stronger response.
- Asbestos induced c-jun expression in tracheal cells without c-fos induction, and increased AP-1 DNA-binding activity in both cell types.
Conclusions:
- Persistent induction of c-fos and c-jun by asbestos suggests a mechanism for chronic cell proliferation.
- Activation of the AP-1 transcription factor pathway is implicated in asbestos-induced carcinogenesis.
- Findings provide insights into the molecular pathways leading to asbestos-related cancers.